American Society of Hematology, Blood Advances, 23(3), p. 3968-3972, 2019
DOI: 10.1182/bloodadvances.2019000181
Full text: Download
Key Points UBE2T is frequently amplified and/or overexpressed and is required for homologous recombination activity in multiple myeloma cells. UBE2T is a potential therapeutic target to increase chemosensitivity in multiple myeloma cells.